Comment Letter | Payment Reimbursement and Managed Care

HFMA Comments on Most Favored Nation (MFN) Model Interim Final Rule

Comment Letter | Payment Reimbursement and Managed Care

HFMA Comments on Most Favored Nation (MFN) Model Interim Final Rule

In a comment letter to CMS regarding the Most Favored Nation (MFN) Model Interim Final Rule (IFC), published in the Federal Register on November 27, 2020, HFMA noted that its members request that CMS withdraw the MFN Model immediately and begin a process of working with impacted stakeholders to develop and propose a payment model pilot that will actually address this root cause of unchecked inflation in  drug costs – manufacturer prices. HFMA believes any model that addresses manufacturer prices should not just address separately payable Part B drugs, but all drugs covered by Medicare Parts A, B, C and D. The letter addresses key concerns of HFMA’s members in detail. Specific concerns about the MFN Model IFC addressed in the letter include its:

  • Adverse Impact to Medicare Beneficiaries and Providers Who Administer High Volumes of MFN Covered Drugs
  • Misappropriation of the Center for Medicare & Medicaid Innovation’s (CMMI’s) Writ Subvert Congress’s Authority and Implement a National Payment Cut for Selected Separately Payable Par B Drugs
  • Failure to Give Stakeholders an Adequate Notice and Opportunity to Comment as Required by the Administrative Procedures Act (APA)
  • Scope and Timing

Download the comment letter

Sign up for a free guest account and get access to five free articles every month.


Related Articles | Payment Reimbursement and Managed Care

How To | Cost Effectiveness of Health

Financial Sustainability Report: August 2021

The August 2021 issue of the Financial Sustainability Report, sponsored by Kaufman Hall, explores the impacts of COVID-19 on hospital cost reporting and financial statements, and why a hospital’s future payment levels may depend on its due diligence around these processes today.

Sponsored Content | Price Transparency

61% of hospitals say future compliance with price transparency will impact financial processes: HFMA poll

An HFMA-Strata survey found 61% of hospitals and health systems are revamping financial processes in light of price transparency.

Column | Healthcare Reform

Two infrastructure bills have significant implications for healthcare and bipartisanship

Congress’ handling of two mammoth bills may well determine the political tone in Washington and whether there will be any room for bipartisanship for the remainder of President Joe Biden’s term.

Fact Sheet | Payment Reimbursement and Managed Care

FY 2022 Skilled Nursing Facilities PPS Final Rule Summary

HFMA presents a detailed summary of the final rule pertaining to the fiscal year 2022 payment rates under the Medicare skilled nursing facility prospective payment system.